Emergency Heart Failure Mortality Risk Grade (EHMRG)
Predicts 7-day mortality in emergency department patients with acute heart failure from triage vital signs, creatinine, potassium, troponin, active cancer and home metolazone (Ontario derivation and validation, Lee 2012).
Score interpretation
7-day mortality 0.3 % in the derivation cohort.
→ Low short-term risk; discharge decisions also need clinical stability and follow-up within 7 days.
7-day mortality 0.3 % in the derivation cohort.
→ Low short-term risk; ensure early follow-up and guideline-directed therapy.
7-day mortality 0.7 % in the derivation cohort.
→ Intermediate risk; decide on admission with clinical judgement.
7-day mortality 1.9 % in the derivation cohort.
→ Higher risk; admission usually appropriate.
7-day mortality 3.5 % in the derivation cohort.
→ High risk: admit with close monitoring.
7-day mortality 8.2 % in the derivation cohort.
→ Highest risk: admit to a monitored bed; senior review and escalation plan.
Interpretation bands for the EHMRG. Apply clinical judgement and local guidance.
References
- Lee DS et al. Prediction of Heart Failure Mortality in Emergent Care: A Cohort Study. Ann Intern Med. 2012;156(11):767-775.
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.